-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Quoin Pharmaceuticals, Ltd. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2021 to Q3 2024.
- Quoin Pharmaceuticals, Ltd. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $178K, a 10.3% decline year-over-year.
- Quoin Pharmaceuticals, Ltd. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $640K.
- Quoin Pharmaceuticals, Ltd. annual Nonoperating Income (Expense) for 2023 was $692K.
- Quoin Pharmaceuticals, Ltd. annual Nonoperating Income (Expense) for 2022 was -$124K, a 99.2% increase from 2021.
- Quoin Pharmaceuticals, Ltd. annual Nonoperating Income (Expense) for 2021 was -$15.4M, a 3520% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)